- Home
- OBIO vs DLNG Comparison
OBIO vs DLNG Comparison
Compare OBIO & DLNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OBIO
- DLNG
- Stock Information
- Founded
- OBIO 2017
- DLNG 2013
- Country
- OBIO United States
- DLNG Greece
- Employees
- OBIO N/A
- DLNG N/A
- Industry
- OBIO Medicinal Chemicals and Botanical Products
- DLNG Marine Transportation
- Sector
- OBIO Health Care
- DLNG Consumer Discretionary
- Exchange
- OBIO Nasdaq
- DLNG Nasdaq
- Market Cap
- OBIO 118.8M
- DLNG 129.0M
- IPO Year
- OBIO N/A
- DLNG 2013
- Fundamental
- Price
- OBIO $2.57
- DLNG $3.52
- Analyst Decision
- OBIO Strong Buy
- DLNG
- Analyst Count
- OBIO 4
- DLNG 0
- Target Price
- OBIO $14.00
- DLNG N/A
- AVG Volume (30 Days)
- OBIO 403.6K
- DLNG 36.0K
- Earning Date
- OBIO 08-12-2025
- DLNG 09-09-2025
- Dividend Yield
- OBIO N/A
- DLNG 5.54%
- EPS Growth
- OBIO N/A
- DLNG 53.29
- EPS
- OBIO N/A
- DLNG 1.10
- Revenue
- OBIO $2,944,000.00
- DLNG $157,455,000.00
- Revenue This Year
- OBIO $20.47
- DLNG N/A
- Revenue Next Year
- OBIO $11.45
- DLNG $0.37
- P/E Ratio
- OBIO N/A
- DLNG $3.22
- Revenue Growth
- OBIO 41.61
- DLNG N/A
- 52 Week Low
- OBIO $2.37
- DLNG $3.18
- 52 Week High
- OBIO $7.04
- DLNG $5.65
- Technical
- Relative Strength Index (RSI)
- OBIO 40.46
- DLNG 43.90
- Support Level
- OBIO $2.50
- DLNG $3.58
- Resistance Level
- OBIO $2.75
- DLNG $3.65
- Average True Range (ATR)
- OBIO 0.18
- DLNG 0.10
- MACD
- OBIO -0.03
- DLNG 0.00
- Stochastic Oscillator
- OBIO 11.47
- DLNG 17.65
About OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.
About DLNG Dynagas LNG Partners LP Common Units
Dynagas LNG Partners LP is a limited partnership company focused on owning and operating high specification and versatile LNG carriers that are employed on multi-year contracts with international energy companies, providing the benefits of stable cash flows and high utilization rates. The company defines charters of two years or more as multi-year charters. Its current LNG Carrier fleet is optimized for trading flexibility. In addition to conventional trade, part of LNG Carrier fleet is assigned with Ice Class 1A FS notation and are winterized which enables trade in subzero and ice bound conditions.